Actinium Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| SETH SANDESH | Chief Executive Officer | Tax Withholding | 120,900 | $1.71 | $206,739 | 184,481 | Aug 18, 2025 |
| SETH SANDESH | Chief Executive Officer | Award / Grant | 300,000 | — | — | 305,381 | Aug 17, 2022 |
| Berger Mark Stanley | Chief Medical Officer | X | 3,500 | $0.60 | $2,100 | 22,500 | Mar 5, 2019 |
| SETH SANDESH | Chairman & CEO | X | 8,125 | $0.60 | $4,875 | 161,458 | Feb 21, 2019 |
| SETH SANDESH | Chairman & CEO | Purchase | 10,000 | $0.44 | $4,400 | 153,333 | Dec 10, 2018 |
| O'Loughlin Steve | Principal Financial Officer | Purchase | 10,000 | $0.44 | $4,400 | 35,500 | Dec 10, 2018 |
| Ludwig Dale L. | Chief Scientific Officer | Purchase | 10,000 | $0.45 | $4,500 | 10,000 | Nov 19, 2018 |
| SETH SANDESH | CEO | Purchase | 10,000 | $0.79 | $7,900 | 143,333 | Jul 17, 2018 |
| O'Loughlin Steve | Principal Financial Officer | Purchase | 12,000 | $0.50 | $6,000 | 25,500 | Jun 15, 2018 |
| SETH SANDESH | Chairman & CEO | Purchase | 5,000 | $0.38 | $1,900 | 133,333 | Apr 19, 2018 |
| Berger Mark Stanley | Chief Medical Officer | Other | 14,000 | $0.50 | $7,000 | 19,000 | Mar 6, 2018 |
| SETH SANDESH | Chairman & CEO | Other | 52,500 | $0.50 | $26,250 | 128,333 | Mar 6, 2018 |
| Ray Nitya G. | Executive VP | Other | 10,000 | $0.50 | $5,000 | 20,000 | Mar 6, 2018 |
| Steinhart Richard I | — | Other | 7,000 | $0.50 | $3,500 | 9,500 | Mar 6, 2018 |
| O'Loughlin Steve | Principal Financial Officer | Other | 10,000 | $0.50 | $5,000 | 13,500 | Mar 6, 2018 |
| Shetty Ajit | — | Purchase | 22,730 | $0.43 | $9,774 | 22,730 | Feb 28, 2018 |
| SETH SANDESH | Chairman & CEO | Purchase | 33,333 | $0.75 | $25,000 | 75,833 | Aug 2, 2017 |
| Ray Nitya G. | Executive Vice President | Purchase | 10,000 | $0.75 | $7,500 | 10,000 | Aug 2, 2017 |
| Berger Mark Stanley | Chief Medical Officer | Purchase | 5,000 | $1.11 | $5,550 | 5,000 | Jun 15, 2017 |
| SETH SANDESH | Chairman and CEO | Purchase | 2,500 | $1.17 | $2,925 | 37,500 | Jun 15, 2017 |
| O'Loughlin Steve | Principal Financial Officer | Purchase | 3,500 | $1.17 | $4,095 | 3,500 | Jun 15, 2017 |
| SETH SANDESH | Executive Chairman | Purchase | 5,000 | $0.88 | $4,400 | 35,000 | Dec 30, 2016 |
| SETH SANDESH | Executive Chairman | Purchase | 5,000 | $0.98 | $4,900 | 30,000 | Dec 12, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 1,500 | $1.81 | $2,715 | 4,877,488 | Aug 31, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 12,002 | $1.71 | $20,523 | 4,927,488 | Aug 29, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 400 | $1.73 | $692 | 4,952,488 | Aug 15, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 100 | $1.81 | $181 | 4,961,956 | Jul 12, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 800 | $1.80 | $1,440 | 4,965,056 | Jul 8, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 10,500 | $1.80 | $18,900 | 4,987,046 | Jul 5, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 3,617 | $1.85 | $6,691 | 5,019,936 | Jul 1, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 33,619 | $1.90 | $63,876 | 5,155,986 | Jun 15, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 6,790 | $2.02 | $13,716 | 5,189,605 | Jun 2, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 9,036 | $2.17 | $19,608 | 5,207,595 | May 31, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 200 | $1.94 | $388 | 5,376,845 | May 26, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 400 | $1.90 | $760 | 5,426,913 | May 25, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 19,759 | $2.07 | $40,901 | 5,483,090 | Apr 22, 2016 |
| Memorial Sloan-Kettering Cancer Center | — | Sale | 3,420 | $2.07 | $7,079 | 5,552,387 | Apr 19, 2016 |
| SETH SANDESH | — | Purchase | 5,000 | $2.00 | $10,000 | 15,000 | Apr 15, 2016 |
| TRAVERSA SERGIO | — | Purchase | 2,000 | $2.02 | $4,040 | 2,000 | Apr 15, 2016 |
| Nicholson, C. David | — | Purchase | 5,000 | $2.00 | $10,000 | 15,000 | Apr 14, 2016 |
| DAVE KAUSHIK J | CEO and Interim CFO | Purchase | 2,000 | $2.01 | $4,020 | 88,500 | Apr 14, 2016 |
| Steinhart Richard I | — | Purchase | 2,500 | $2.01 | $5,025 | 2,500 | Apr 14, 2016 |
| DAVE KAUSHIK J | President, CEO and Interim CFO | Tax Withholding | 16,000 | $2.45 | $39,200 | 73,083 | May 7, 2015 |
| CICIC DRAGAN | COO and Chief Medical Officer | Tax Withholding | 560 | $2.52 | $1,411 | 560 | May 7, 2015 |
| AHLB Holdings, LLC | — | Other | 5,702,387 | — | — | 5,702,387 | May 6, 2015 |
| CICIC DRAGAN | COO and Chief Medical Officer | Award / Grant | 3,500 | $5.55 | $19,425 | 3,500 | Feb 21, 2014 |
| SETH SANDESH | — | Award / Grant | 10,000 | $3.60 | $36,000 | — | Aug 8, 2013 |
| TRAVERSA SERGIO | Interim CFO | Award / Grant | 10,000 | $3.60 | $36,000 | — | Aug 8, 2013 |
| MAZANET ROSEMARY | — | Purchase | 100 | $3.95 | $395 | 100 | May 15, 2013 |